Market revenue in 2020 | USD 44,225.4 million |
Market revenue in 2028 | USD 162,918.0 million |
Growth rate | 17.7% (CAGR from 2020 to 2028) |
Largest segment | (crispr)/cas9 |
Fastest growing segment | Meganuclease |
Historical data covered | 2017 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
Key market players worldwide | Thermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.
(crispr)/cas9 was the largest segment with a revenue share of 42.77% in 2020. Horizon Databook has segmented the Asia Pacific mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.
Asia Pacific’s market is expected to witness lucrative growth over the forecast period, with Japan and China at the forefront. China was reported to be the first country to have successfully transferred genetically edited cells into humans, in an attempt to boost immunity and treat lung cancer.
Strategic initiatives undertaken by international companies to expand their presence in this region due to a large customer base is expected to create numerous opportunities for regional growth. Ethical, social, and legal issues related to manipulation of genes can be attributed to the limited contribution from this region.
Developing economies in Asia Pacific possess major potential for growth. With increase in investments in developing economies such as China, the market is expected to witness lucrative growth. The 7th Plant Genomics and Gene Editing Congress: Asia was held virtually in April 2021. This conference aimed to accelerate collaborations between stakeholders attending the meeting. Such initiatives are expected to positively impact market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific mutation detection kits in genome editing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account